Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amir Nikooienejad

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Bayesian Analysis|June 11, 2021
On the Existence of Uniformly Most Powerful Bayesian Tests With Application to Non-Central Chi-Squared TestsAmir Nikooienejad, Valen E Johnson
The Annals of Applied Statistics|January 18, 2021
BAYESIAN VARIABLE SELECTION FOR SURVIVAL DATA USING INVERSE MOMENT PRIORSAmir Nikooienejad, Wenyi Wang, Valen E Johnson
Bioinformatics (Oxford, England)|January 8, 2016
Bayesian variable selection for binary outcomes in high-dimensional genomic studies using non-local priorsAmir Nikooienejad, Wenyi Wang, Valen E Johnson
The Journal of Clinical Endocrinology and Metabolism|November 25, 2020
Dual GIP and GLP-1 Receptor Agonist Tirzepatide Improves Beta-cell Function and Insulin Sensitivity in Type 2 DiabetesMelissa K Thomas, Amir Nikooienejad, Ross Bray, et al.
Diabetes, Obesity & Metabolism|January 19, 2021
The dual glucose-dependent insulinotropic peptide and glucagon-like peptide-1 receptor agonist, tirzepatide, improves lipoprotein biomarkers associated with insulin resistance and cardiovascular risk in patients with type 2 diabetesJonathan M Wilson, Amir Nikooienejad, Deborah A Robins, et al.
Diabetes Care|April 16, 2020
Effects of Novel Dual GIP and GLP-1 Receptor Agonist Tirzepatide on Biomarkers of Nonalcoholic Steatohepatitis in Patients With Type 2 DiabetesMark L Hartman, Arun J Sanyal, Rohit Loomba, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Bayesian Analysis|June 11, 2021
On the Existence of Uniformly Most Powerful Bayesian Tests With Application to Non-Central Chi-Squared TestsAmir Nikooienejad, Valen E Johnson
The Annals of Applied Statistics|January 18, 2021
BAYESIAN VARIABLE SELECTION FOR SURVIVAL DATA USING INVERSE MOMENT PRIORSAmir Nikooienejad, Wenyi Wang, Valen E Johnson
Bioinformatics (Oxford, England)|January 8, 2016
Bayesian variable selection for binary outcomes in high-dimensional genomic studies using non-local priorsAmir Nikooienejad, Wenyi Wang, Valen E Johnson
The Journal of Clinical Endocrinology and Metabolism|November 25, 2020
Dual GIP and GLP-1 Receptor Agonist Tirzepatide Improves Beta-cell Function and Insulin Sensitivity in Type 2 DiabetesMelissa K Thomas, Amir Nikooienejad, Ross Bray, et al.
Diabetes, Obesity & Metabolism|January 19, 2021
The dual glucose-dependent insulinotropic peptide and glucagon-like peptide-1 receptor agonist, tirzepatide, improves lipoprotein biomarkers associated with insulin resistance and cardiovascular risk in patients with type 2 diabetesJonathan M Wilson, Amir Nikooienejad, Deborah A Robins, et al.
Diabetes Care|April 16, 2020
Effects of Novel Dual GIP and GLP-1 Receptor Agonist Tirzepatide on Biomarkers of Nonalcoholic Steatohepatitis in Patients With Type 2 DiabetesMark L Hartman, Arun J Sanyal, Rohit Loomba, et al.
Pageof 1